Study
Geroprotective insights into the natural metabolite spermidine in aging and age-related diseases
A comprehensive review finds spermidine extends lifespan in multiple organisms and improves biomarkers in humans, but a 12-month Phase IIb trial showed no memory improvement in older adults with cognitive decline.
Summary Does spermidine slow aging or improve health in people? Show / hide ↓
Researchers reviewed studies of spermidine, a natural substance found in foods and the body, from cells, animals, and people. In mice, it improved cell recycling, called autophagy, and helped mitochondria, the parts of cells that make energy. Small human studies found that low doses improved health measures, and 40 milligrams daily was safe for 28 days in older men. However, a 12-month trial in older adults with memory concerns found no improvement in memory or other measured health markers compared with a placebo, an inactive treatment. Population studies linked higher food intake of spermidine with lower death rates, but these studies cannot show that spermidine caused the benefit.
What this means for you: Do not buy spermidine supplements specifically for longevity or memory based on this evidence. Short-term safety looks reassuring, but benefits in people remain unproven and the main memory trial was negative.
conflicting evidenceResearchers reviewed the geroprotective properties of spermidine across mechanistic, preclinical, and clinical evidence. Spermidine levels naturally decline with age in human blood cells. The review identifies the eIF5A-TFEB axis as a central mechanism: spermidine promotes hypusination of eIF5A, which in turn supports translation of TFEB and ATG7, driving autophagic flux. In preclinical models, a 6-month spermidine regimen attenuated age-associated phenotypes in mice and reduced telomere attrition. Spermidine also improved mitochondrial function and ATP production in cell and animal models. On the human side, 3.3 mg/day from rice germ extract improved biomarkers of autophagy and cardiometabolic health. High-purity spermidine at 40 mg/day for 28 days was safe and well-tolerated in older men. However, the 12-month Phase IIb SmartAge trial in older adults with subjective cognitive decline found no improvement in memory or biomarkers versus placebo. Exploratory analyses suggested possible effects on verbal memory and tissue inflammation. Population studies linked higher dietary spermidine intake to lower cardiovascular and cancer mortality, though effect sizes were not reported. The authors caution that spermidine should not be considered for routine preventive use in longevity medicine until larger, long-term trials confirm efficacy and optimal dosing.
Spermidine is a versatile, multi-targeted candidate geroprotector, but evidence needed for routine human use is still emerging.
The SmartAge trial was Phase IIb with a moderate sample size. The negative primary outcome tempers enthusiasm for cognitive applications. Spermidine's effects may be disease-context-dependent: elevated polyamines were associated with increased risk of post-stroke cognitive impairment, and spermidine in the glioblastoma microenvironment drove tumor progression by inhibiting CD8+ T-cell function.
Cited by
1 encyclopedia entries reference this study.